Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-01-24, Stock:LLY, The news for the past five days is as follows:
2018-01-17: NEWS1: U.S. Senate committee advances Azar nomination as health secretary.NEWS2: Key U.S. Senate committee advances Azar nomination for HHS secretary.NEWS3: Merck Strong on Confirmatory Phase III Lung Cancer Study.NEWS4: Nektar Boasts Strong Pipeline, Competition Remains a Woe.NEWS5: A Rally in Eli Lilly Could Heal Traders, Investors.NEWS6: Is Eli Lilly and Company a Buy in 2018?.NEWS7: Is Eli Lilly and Company a Buy in 2018?.NEWS8: Teva Pharmaceutical: Still Focused on New Product Launches.
2018-01-18: NEWS1: Merck’s & Co.’s Valuation in January 2018.NEWS2: Elanco Innovations Named Best Products for 2017.NEWS3: See what the IHS Markit Score report has to say about Eli Lilly And Co..NEWS4: GALLIPRANT® (grapiprant tablets) Named Best Companion Animal Product for 2017.
2018-01-19: NEWS1: Pharma And Biotech Dividend Stocks That Will Add Value To Your Portfolio.
2018-01-22: NEWS1: Merck Reports Positive Phase III Liver Cancer Data on Keytruda.NEWS2: Morning Movers: Juno Soars on Celgene Takeout; GE Slumps on Merrill Cut.NEWS3: Eli Lilly's Challenges Leaves Credit Suisse With A 'Sour Taste'.NEWS4: See what the IHS Markit Score report has to say about Eli Lilly And Co..NEWS5: Elanco Animal Health Announces U.S. Food and Drug Administration (FDA) Approval of Credelio® (lotilaner) to Treat and Protect Against Ticks and Fleas.NEWS6: Eli Lilly Animal Health Unit Announces FDA Approval Of Credelio - Quick Facts.NEWS7: Eli Lilly Animal Health Unit Announces FDA Approval Of Credelio - Quick Facts.NEWS8: Some Branded Drugs Going Generic In 2018.NEWS9: Some Branded Drugs Going Generic In 2018.
2018-01-23: NEWS1: A Deeper Look at Nektar Therapeutics’ Licensing Agreements.NEWS2: Analysts Take Action on Health Care Stocks.NEWS3: Analysts’ Ratings for Nektar Therapeutics in January 2018.NEWS4: About Those Soaring Pharma Profits.

Answer: Decrease